AzTrials
AzTrials

PsychopathyNCT01428349

Matching Cognitive Remediation to Cognitive Deficits in Substance-Abusing Inmates

A study testing Cognitive Remediation in people with Psychopathy and Personality Disorders, run by University of Wisconsin, Madison at 2 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record

Search all trials

Trial summary

This is a 2 -year NIDA funded grant (Co-PIs: Joseph P. Newman, John Curtin, and Carl Lejuez) that examines whether recent progress in characterizing the cognitive deficits associated with psychopathic and externalizing offenders may be used to develop better therapeutic interventions to treat their substance abuse and… Read more about this study

Who is it for?
Ages 18 to 45 years, men only
Conditions the study is for
Psychopathy, Personality Disorders
What is being tested?
Cognitive Remediation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
180 participants
Where
2 sitesUnited States
Study dates
May 2011to May 2013
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Men only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Male,
  • ages 18-45 years,
  • elevated scores of psychopathy or externalizing measures

Who cannot join

  • currently taking psychotropic medication,
  • below a 4th grade reading level,
  • history or current learning disability,
  • history of head trauma with lasting effects,
  • current diagnosis of PTSD,
  • Bipolar, or
  • psychosis

Trial locations and contacts

2 sites in 1 country.

United States2 sites
  • Fox Lake Correctional Institution

    Fox Lake, Wisconsin, 53933

  • Oshkosh Correctional Institution

    Oshkosh, Wisconsin, 54901

Other trials in United States

About this study

This is a 2 -year NIDA funded grant (Co-PIs: Joseph P. Newman, John Curtin, and Carl Lejuez) that examines whether recent progress in characterizing the cognitive deficits associated with psychopathic and externalizing offenders may be used to develop better therapeutic interventions to treat their substance abuse and other self-control problems. Inmates with externalizing or psychopathy will receive one of two computer-based interventions to remediate the core cognitive skills that have been linked to self-regulation deficits in the two groups. One intervention (ACC) targets the affective cognitive control deficits associated with externalizing offenders whereas the other intervention (ATC) targets the attention to context deficits associated with psychopathic offenders. The specific components of the project include: selection and randomization of inmates; pre- and post-treatment behavioral and brain-related (ERP and Startle) measures to evaluate the impact and specificity of the ACC and ATC treatments; and 6 sessions of behavioral (e.g. computerized) and verbal training in ACC or ATC.

Being tested
Cognitive Remediation
Keywords
Incarcerated offenders, emotionally reactive, emotionally stable, psychopathy
Medical subject headings
Antisocial Personality Disorder, Personality Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cognitive RemediationOther

    Computer training on 3 tasks that targets the attention to context deficits associated with psychopathic offenders. Participants complete 6 training sessions, that include the tasks, feedback and real-world translational examples.

  • Cognitive RemediationOther

    Computer training on 3 tasks that targets the affective cognitive control deficits associated with externalizing offenders. Participants complete 6 training sessions, that include the tasks, feedback and real-world translational examples.

Study groups in NCT01428349
Study groupRoleWhat they receive
Attention to ContextExperimentalNot described
Receives: Other: Cognitive Remediation
Affective Cognitive ControlExperimentalNot described
Receives: Other: Cognitive Remediation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Psychophysiological change from pre-treatment to post-treatment

    We will measure electrophysiology (EEG), startle responses (EMG measured in microvolts), and behavioral responses on six tasks that measure such processes as affective regulation, distress tolerance, cognitive control, selective attention, and attending to context.

    Measured: 6 weeks after pre-testing

Secondary outcomes (1)
  1. Frequency of Conduct Reports

    Assess change in the frequency of institution conduct reports post-treatment. We will compare frequency of these reports pre-treatment and post-treatment.

    Measured: within 3 months of participation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Sep 2011 (estimated)
  2. Study startMay 2011
  3. Primary completionMay 2013
  4. Study completionMay 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Participant
Enrolment
180 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01428349
Sponsor's protocol ID
SE-2011-0103
Status last verified
Nov 2011
First submitted
17 Aug 2011
Last updated
2 Jun 2015
Results posted
No
Data monitoring committee
Yes

Publications

  • Baskin-Sommers AR, Curtin JJ, Newman JP. Altering the Cognitive-Affective Dysfunctions of Psychopathic and Externalizing Offender Subtypes with Cognitive Remediation. Clin Psychol Sci. 2015 Jan 1;3(1):45-57. doi: 10.1177/2167702614560744.

    PubMed 25977843

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in